<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03226184</url>
  </required_header>
  <id_info>
    <org_study_id>2167/2013</org_study_id>
    <nct_id>NCT03226184</nct_id>
  </id_info>
  <brief_title>Sterilizing Effects of the Erbium:YAG Laser Upon Metal Implants</brief_title>
  <official_title>Sterilizing Effects of the Erbium:YAG Laser Upon Metal Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:&#xD;
&#xD;
      Even today, postoperative infection is the commonest complications after surgery although all&#xD;
      aseptic precautions are taken and causes significant postoperative morbidity, mortality,&#xD;
      prolongs hospital stay, and increases costs. Infections that are related to orthopaedic&#xD;
      procedures are considered particularly severe when implantation materials are used which&#xD;
      further increases the risk of infection and holds the risk of biofilm formation. This is of&#xD;
      particular concern since biofilm-mediated infections are difficult to diagnose and effective&#xD;
      treatments are lacking. Therefore, new strategies for implant infection are currently being&#xD;
      researched worldwide. In this study the relatively new approach for infection control by&#xD;
      using an Er:YAG laser was adapted to an orthopaedic and traumatologic setting. This laser&#xD;
      vaporizes all water containing cells in a very effective, precise and predictable manner and&#xD;
      shows only a minimal thermal damage.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      For preliminary testing 42 steel pins and 42 plates were cultivated with cocultures for 2&#xD;
      weeks. The minimally necessary laser energy for biofilm removal was determined. We&#xD;
      subsequently compared the effectiveness of biofilm removal with the Er:YAG laser and a&#xD;
      cleansing of the metal implants with Octenidine soaked gauze. The temperature rise within the&#xD;
      metal during the laser procedure was also measured.&#xD;
&#xD;
      In order to achieve an approximation to a clinical setting we want to compared the same&#xD;
      effectiveness of biofilm removal similarly on steel pins directly after explantation from&#xD;
      patients treated with external fixators for at least 2 weeks. Sonication and SEM will be used&#xD;
      for analysis.&#xD;
&#xD;
      Preliminary Results Laser fluences exceeding 2.8J/cm2 caused a complete extinction of all&#xD;
      living cells by a single laser impulse. Temperature rise within the implant is dependent on&#xD;
      repetition frequency but overall negligible.&#xD;
&#xD;
      The effectiveness of biofilm removal after cleansing with Octenidine soaked gauze and&#xD;
      irradiation with the Er:YAG laser will be evaluated on cultivated and extracted pins.&#xD;
&#xD;
      Conclusions We want to compare the effectiveness of the Er:YAG laser and Octenidine in the&#xD;
      removal of biofilms from half-pins. We hypothesize that thee Er:YAG laser offers a secure,&#xD;
      complete and non toxic removal of all kinds of pathogens from steel implants without damaging&#xD;
      the implant or possible development of resistances. The precise non-contact removal of&#xD;
      adjacent tissue could be an advantage over other disinfectants.&#xD;
&#xD;
      Level of Evidence (II-a)&#xD;
&#xD;
      Clinical Relevance:&#xD;
&#xD;
      Having one more arrow in the quiver for disinfection of percutaneous implants or for septic&#xD;
      revision surgery when osteosynthesis equipment or arthroplasties are meant to be left in&#xD;
      place would be extremely desirable.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 1, 2012</start_date>
  <completion_date type="Anticipated">October 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Completeness of biofilm removal</measure>
    <time_frame>2 years</time_frame>
    <description>Is the Er:YAG laser able to remova a microbial biofilm from cultivated or infected implants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>2 years</time_frame>
    <description>Are there side effect to be expected from laser Irradiation either for the implant or for the surrounding tissue in a possible clinical setting</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Orthopedic Devices Associated With Misadventures, Prosthetic and Other Implants, Materials and Accessory Devices</condition>
  <eligibility>
    <study_pop>
      <textblock>
        same as inclusion criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        All patients that are treated with external fixators for at least 2 weeks and patients&#xD;
        whose implants have to be removed during septic revision surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Lukas K Kriechbaumer, MD</last_name>
    <phone>+43 (0) 5 7255 - 57156</phone>
    <email>lukikriechbaumer@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sylvia NÃ¼rnberger, MSc</last_name>
    <phone>+43 1 40400 59440</phone>
    <email>sylvia.nuernberger@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Clinic of Traumatology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukas K Kriechbaumer, MD</last_name>
      <phone>+43 (0) 5 7255</phone>
      <phone_ext>57156</phone_ext>
      <email>lukikriechbaumer@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Wolfgang Happak, Prof. MD</last_name>
      <phone>+43 (0)1 40400</phone>
      <phone_ext>69860</phone_ext>
    </contact_backup>
    <investigator>
      <last_name>Wolfgang Happak, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lukas Kriechbaumer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>July 19, 2017</study_first_submitted>
  <study_first_submitted_qc>July 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>July 19, 2017</last_update_submitted>
  <last_update_submitted_qc>July 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Lukas Kriechbaumer</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

